Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Shanghai Yingli Pharmaceutical Co. Ltd.
Sponsor

Shanghai Yingli Pharmaceutical Co. Ltd.

Building 4 Room 311, No 576 Li Bing Road, Testing Zone, 201203

About the sponsor

Shanghai Yingli Pharmaceutical Co. Ltd. is involved in clinical research for relapsed or refractory peripheral T/NK cell lymphoma, with a specific focus on peripheral T-cell lymphoma and related aggressive lymphoid malignancies.

  • Peripheral T/NK Cell Lymphoma
  • Relapsed or Refractory Disease
  • Lymphoid Neoplasms

The sponsor’s research activity centers on treatment options for patients with difficult-to-treat hematologic cancers in the oncology setting.

About Specializations

Shanghai Yingli Pharmaceutical Co. Ltd. runs clinical trials in conditions such as Cutaneous T-cell lymphoma, Cutaneous T-cell lymphoma refractory, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Cutaneous T-cell lymphoma+1

Not recruiting
InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Linperlisib
  • Sponsor:Shanghai Yingli Pharmaceutical Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.